Milani M - Search Results

1

Prediction of postoperative recurrence-free survival in non-small cell lung cancer by using an internationally validated gene expression model.

Mitra R, Lee J, Jo J, Milani M, McClintick JN, Edenberg HJ, Kesler KA, Rieger KM, Badve S, Cummings OW, Mohiuddin A, Thomas DG, Luo X, Juliar BE, Li L, Mesaros C, Blair IA, Srirangam A, Kratzke RA, McDonald CJ, Kim J, Potter DA. Mitra R, et al. Among authors: milani m. Clin Cancer Res. 2011 May 1;17(9):2934-46. doi: 10.1158/1078-0432.CCR-10-1803. Epub 2011 Jan 17. Clin Cancer Res. 2011. PMID: 21242119 Free PMC article.

2

The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.

Srirangam A, Milani M, Mitra R, Guo Z, Rodriguez M, Kathuria H, Fukuda S, Rizzardi A, Schmechel S, Skalnik DG, Pelus LM, Potter DA. Srirangam A, et al. Among authors: milani m. J Thorac Oncol. 2011 Apr;6(4):661-70. doi: 10.1097/JTO.0b013e31820c9e3c. J Thorac Oncol. 2011. PMID: 21270666 Free PMC article.

3

Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.

Milani M, Jha G, Potter DA. Milani M, et al. Clin Med Ther. 2009 Mar 31;1:141-156. doi: 10.4137/cmt.s9. Clin Med Ther. 2009. PMID: 19794821 Free PMC article.

4

CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET).

Mitra R, Guo Z, Milani M, Mesaros C, Rodriguez M, Nguyen J, Luo X, Clarke D, Lamba J, Schuetz E, Donner DB, Puli N, Falck JR, Capdevila J, Gupta K, Blair IA, Potter DA. Mitra R, et al. Among authors: milani m. J Biol Chem. 2011 May 20;286(20):17543-59. doi: 10.1074/jbc.M110.198515. Epub 2011 Mar 14. J Biol Chem. 2011. PMID: 21402692 Free PMC article.

5

The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells.

Wang W, Ostlie NS, Conti-Fine BM, Milani M. Wang W, et al. Among authors: milani m. J Immunol. 2004 Jan 1;172(1):97-103. doi: 10.4049/jimmunol.172.1.97. J Immunol. 2004. PMID: 14688314

6

CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis.

Conti-Fine BM, Milani M, Wang W. Conti-Fine BM, et al. Among authors: milani m. Ann N Y Acad Sci. 2008;1132:193-209. doi: 10.1196/annals.1405.042. Ann N Y Acad Sci. 2008. PMID: 18567869 Review.

7

Myasthenia gravis: past, present, and future.

Conti-Fine BM, Milani M, Kaminski HJ. Conti-Fine BM, et al. Among authors: milani m. J Clin Invest. 2006 Nov;116(11):2843-54. doi: 10.1172/JCI29894. J Clin Invest. 2006. PMID: 17080188 Free PMC article. Review.

8

C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.

Wang W, Milani M, Ostlie N, Okita D, Agarwal RK, Caspi RR, Conti-Fine BM. Wang W, et al. Among authors: milani m. J Immunol. 2007 Jun 1;178(11):7072-80. doi: 10.4049/jimmunol.178.11.7072. J Immunol. 2007. PMID: 17513756 Free PMC article.

9

Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.

Ostlie N, Milani M, Wang W, Okita D, Conti-Fine BM. Ostlie N, et al. Among authors: milani m. J Immunol. 2003 Jan 1;170(1):604-12. doi: 10.4049/jimmunol.170.1.604. J Immunol. 2003. PMID: 12496449

10

Epitope repertoire of Th1 and Th2 cells reactive with the mouse muscle AChR alpha subunit in C57Bl/6 mice.

Wang W, Milani M, Okita D, Ostlie N, Conti-Fine BM. Wang W, et al. Among authors: milani m. Ann N Y Acad Sci. 2003 Sep;998:384-7. doi: 10.1196/annals.1254.046. Ann N Y Acad Sci. 2003. PMID: 14592901 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

771 results

Search Page